TRISEQUENS, film-coated tablet 12 tablets
Active ingredients: (17R)-norethindrone acetate, 17β-estradiol
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet12 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRISEQUENS, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) de 12 comprimé(s) bleus, 10 comprimé(s) blancs et 6 comprimé(s) rouges
- Marketing authorisation holder
- NOVO NORDISK
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 10 Jan 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64725221CIP73254882CIP133400932548828Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ESTRADIOLcomprimé blanc | 2 mg · un comprimé | SA |
| ACÉTATE DE NORÉTHISTÉRONEcomprimé blanc | 1 mg · un comprimé | SA |
| ESTRADIOLcomprimé bleu | 2 mg · un comprimé | SA |
| ESTRADIOLcomprimé rouge | 1 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.